Oral Cyclophosphamide Is on the Verge of Extinction as Therapy for Severe Autoimmune Diseases (Especially Lupus): Should Nephrologists Care?

Nephron Clinical Practice
doi 10.1159/000319641
Full Text
Abstract

Available in full text

Date
Authors
Publisher

S. Karger AG

Related search

Harnessing Regulatory T Cells for the Therapy of Lupus and Other Autoimmune Diseases

Immunotherapy
OncologyAllergyImmunology
2009English

Are Culture-Bound Syndromes on the Verge of Extinction?

Progress in Neurology and Psychiatry
PsychiatryMental HealthNeurologyPsychiatric Mental Health
2017English

Commensal Gut-Derived Anaerobes as Novel Therapy for Inflammatory Autoimmune Diseases

2012English

Anticytokine Therapy in Autoimmune Diseases.

Internal Medicine
Internal MedicineMedicine
1999English

Rituximab Therapy for Refractory Autoimmune Thrombocytopenia in Systemic Lupus Erythematosus

Turkish Journal of Haematology
Hematology
2012English

Intravenous Cyclophosphamide Combined With Steroids in Pediatric Onset Severe Lupus Nephritis

International Urology and Nephrology
UrologyNephrology
2012English

Dental Implants in Patients With Oral Autoimmune Diseases

Journal of Research and Practice on the Musculoskeletal System
2019English

Handing Out Grades for Care in Chronic Kidney Disease: Nephrologists Versus Non-Nephrologists

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2007English

Autoimmune Hepatitis as Initial Presentation of Systemic Lupus Erythematosus

Phillippine Journal of Internal Medicine
Internal Medicine
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy